跳至主要内容
临床试验/CTRI/2020/02/023317
CTRI/2020/02/023317尚未招募4 期

A randomised trial of 6 months Intensified anti-tuberculosis and 2 months antiInflammatory treatment for HIV-Infected and HIV-uninfected African and Asianchildren with tuberculous meningitis: Sure Trial. - SURE

university college londonUC0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age:between29daysand <15 years
  • 2.Weight:>=3kg
  • Symptoms compatible with TBM (e.g.fever, vomiting, anorexia, listlessness,headache.
  • 3.CSFresult with abnormalities compatible with TBM(elevated cell count and/or protein with
  • or withoutM.tuberculosisdetected by microscopy or GeneXpert).Physician believes thechild needs immediate initiation of anti-TB drugs.
  • 4.Known (or pending confirmation of) HIV status
  • 5.Parent/legalcarer give informed,written consent
  • 6.Agree for aCSF sampleto be collected andprocessed for chemistry, microscopy,Ziehlâ??
  • Nielsenor auramine stain andmycobacterialculture(in process)and,where available,Xpert
  • (GeneXpert/Rif or Xpert Ultra)prior to commencingtreatmentor when clinically stable todo so. Where patients have already been started on ATT, pre-screening CSF resultsshould beavailable
  • 7.Participantâ??s carer/parentcan comply with the protocol requirements in the opinion of the
  • site investigator
  • 8.Homeaddress accessible for visiting and intending to remain within the recruitment area for
  • follow upperiod ofat least18months

排除标准

  • 1.Recent contact(last 12 months)withknown or suspectedrifampicin-resistant TB
  • 2.Proven drugresistance to rifampicin in the child
  • 3.On ATT for >7 days
  • 4.Severely moribund; high risk of death within 24hours
  • 5.History or presence of known allergy or other contraindication toany first-line anti-
  • tuberculosisdrugs, corticosteroids, or aspirin
  • 6.Pregnancy
  • 7.History ofgastrointestinal (GI)bleeding or bleeding diathesis
  • 8.Activeclinicalinfection with influenza or varicella
  • 9.Grade 4 liver toxicity or other contraindicationsfor taking part in the trial

研究者

发起方
university college londonUC

相似试验